What is the appropriate dose of polyethylene glycol (PEG 3350) for a three-month-old infant?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

PEG Dosing for a Three-Month-Old Infant

For a three-month-old infant with constipation, start with PEG 3350 at 0.8 g/kg/day, though you should be aware that FDA labeling only approves PEG for children 17 years and older, making this off-label use.

Critical FDA Labeling Limitation

The FDA-approved dosing explicitly states "children 16 years of age or under: ask a doctor" 1. The standard adult dose is 17 grams daily 1, but this is not applicable to infants.

Evidence-Based Pediatric Dosing

Despite the FDA restriction, substantial research supports PEG use in infants:

Recommended Starting Dose

  • Initial dose: 0.8-1.0 g/kg/day for infants under 18 months 2, 3
  • For a typical 3-month-old (approximately 6 kg), this translates to 4.8-6 grams daily
  • Adjust the dose to achieve 1-2 soft, painless stools per day 3

Supporting Evidence

The most relevant study specifically examined infants 0-5 months old (n=3 in this age group) and found:

  • Mean initial dose: 0.88 g/kg/day
  • Mean effective maintenance dose: 0.78 g/kg/day
  • 97.6% success rate in relieving constipation
  • Minimal adverse effects (transient diarrhea in 4 patients, resolved with dose adjustment) 2

A larger study of 75 children under 2 years (including infants as young as 1 month) demonstrated:

  • Mean short-term effective dose: 1.1 g/kg/day
  • Mean long-term dose: 0.8 g/kg/day
  • 85% short-term and 91% long-term success rates
  • Excellent safety profile with only mild, dose-dependent diarrhea 3

Practical Implementation

Dosing algorithm:

  1. Calculate weight-based dose: 0.8 g/kg/day as starting point
  2. Mix powder completely in 2-4 ounces of formula, breast milk, or water
  3. Ensure powder is fully dissolved before administration
  4. Titrate dose based on response:
    • If no response in 2-3 days: increase by 0.1-0.2 g/kg/day
    • If diarrhea develops: decrease dose by 0.1-0.2 g/kg/day
  5. Target: 1-2 soft stools daily without straining

Safety Considerations

Common pitfalls to avoid:

  • Do not use clumped or undissolved powder
  • Do not exceed necessary dose (causes diarrhea)
  • Monitor for dehydration if diarrhea occurs
  • Adverse effects are typically mild and dose-dependent 2, 3

Duration of therapy:

  • Mean duration in studies: 6.2 months (range 3 weeks to 21 months) 2
  • Long-term use appears safe in this age group 3

Important Caveats

While the 2023 AGA/ACG guidelines 4 provide strong evidence for PEG efficacy, they focus exclusively on adults with chronic idiopathic constipation. The adult dose of 17 grams daily is completely inappropriate for infants.

The systematic review by 5 confirms that while PEG appears safe in children under 24 months, optimal dosing regimens vary (0.45-1.1 g/kg/day for PEG 3350), and standardized protocols are lacking. However, the weight-based approach of 0.8 g/kg/day represents the most consistent effective dose across multiple studies 2, 3.

This is off-label use requiring informed parental consent and close monitoring, but represents the best available evidence-based approach for this age group.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.